Corvus Pharmaceuticals Inc (CRVS)
2.16
+0.05
(+2.37%)
USD |
NASDAQ |
May 31, 16:00
2.15
-0.01
(-0.46%)
After-Hours: 20:00
Corvus Pharmaceuticals Shareholders Equity (Quarterly): 33.36M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 33.36M |
December 31, 2023 | 38.68M |
September 30, 2023 | 44.29M |
June 30, 2023 | 49.48M |
March 31, 2023 | 48.87M |
December 31, 2022 | 56.12M |
September 30, 2022 | 64.68M |
June 30, 2022 | 80.39M |
March 31, 2022 | 89.72M |
December 31, 2021 | 97.16M |
September 30, 2021 | 105.15M |
June 30, 2021 | 96.40M |
March 31, 2021 | 94.38M |
December 31, 2020 | 72.15M |
September 30, 2020 | 42.35M |
June 30, 2020 | 50.84M |
March 31, 2020 | 60.04M |
December 31, 2019 | 71.11M |
Date | Value |
---|---|
September 30, 2019 | 80.41M |
June 30, 2019 | 89.65M |
March 31, 2019 | 100.70M |
December 31, 2018 | 110.34M |
September 30, 2018 | 118.85M |
June 30, 2018 | 127.40M |
March 31, 2018 | 137.23M |
December 31, 2017 | 84.84M |
September 30, 2017 | 93.74M |
June 30, 2017 | 104.78M |
March 31, 2017 | 118.22M |
December 31, 2016 | 132.80M |
September 30, 2016 | 142.91M |
June 30, 2016 | 151.97M |
March 31, 2016 | 152.55M |
December 31, 2015 | -31.10M |
September 30, 2015 | -25.31M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
33.36M
Minimum
Mar 2024
105.15M
Maximum
Sep 2021
68.26M
Average
67.90M
Median
Shareholders Equity (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | -2.206M |
Enanta Pharmaceuticals Inc | 166.11M |
Oragenics Inc | 2.625M |
Nanoviricides Inc | 10.65M |
MAIA Biotechnology Inc | -5.765M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 40.08M |
Total Liabilities (Quarterly) | 6.72M |